Making the Connection - CME Honolulu, HI
FEBRUARY 29, 2020
Interactive & Engaging
5.75 CME Credits
Cutting Edge Education
Complimentary Breakfast & Lunch
An engaging & entertaining
CME CONFERENCE EXPERIENCE For Healthcare Professionals
Saturday, February 29, 2020
7:30am – Registration & Breakfast
8:00am – 5:00pm – Conference
Hawaii Convention Center
1801 Kalakaua Ave., Honolulu, HI 96815
Parking is $12
$50 per person, On-site: $65 per person
Registration is limited to only 200 professionals.
(Register early, this program will sell out!)
Breakfast: Breakfast items vary
Mid-Morning Snack: Apple & String Cheese
Lunch: Seared Ahi Salad, Spinach, Fingerling Potatoes, Green Beans, Asparagus and Yuzu Vinaigrette
Dessert: Lemon Tapioca with Fresh Fruit
Registration for this conference is now closed.
Held in conjunction with the CME program, it’s life-changing day of education, motivation and empowerment to give people living with diabetes the tools they need to take a more active role in their health. LEARN MORE HERE.
Looking for detailed
and speaker information?
Download the brochure!
Print it, email it, share it.
The Making the Connection brochure is here
to help you spread the word.
Presenter Slide Decks
Download the presentation slide decks ahead of time
and save them to your laptop or tablet!
WHY YOU NEED TO “MAKE THE CONNECTION“
Healthcare professionals who attend Making the Connection will…
- LEARN from the nations LEADING experts in diabetes treatment
- Earn 5.75 CME CREDITS
- Enjoy a healthy & delicious BREAKFAST & LUNCH
- Receive DOWNLOADABLE slide decks of all speaker presentations
- Most importantly, help THEIR PATIENTS reach their treatment goals
WHAT YOU WILL LEARN
We focus on four distinct areas of the most cutting-edge diabetes management strategies:
- Patient-provider relationships with a focus on communication methods to improve adherence and persistence
- Oral agents for the treatment of type 2 diabetes and their effect on cardiovascular health
- Injectable therapies, including insulin, for use in patients with type 2 diabetes and their cardiovascular impact
- Time in range and the unmet needs of type 1 diabetes
“I love attending this CME conference every single year to see what new therapies & trends are on the horizon for my patients with diabetes.”
– MTC Conference Participant 2018
|7:30AM - 8:30AM||Registration & Continental Breakfast
|8:00AM - 8:15AM||Program Overview & Introduction
Steven V. Edelman, MD
|8:15AM - 9:00AM||Understanding and Addressing Problematic Adherence to Oral and Injectable Cardiometabolic Medications
William Polonsky, PhD, CDE
|9:10AM - 10:40AM||The Diabetes Conference of Tomorrow...Today!
Steven V. Edelman, MD; William Polonsky, PhD, CDE; Jeremy H. Pettus, MD; and Schafer Boeder, MD
This session is held in tandem with the TCOYD Conference & Health Fair for people with diabetes
|10:40AM -11:30AM||Break & Visit Health Fair|
|11:30AM -12:30PM||Effective Use of Oral Medications for Type 2 Diabetes: Lowering Cardiovascular Risk While Improving Glycemic Control
Steven V. Edelman, MD
|12:30PM - 1:00PM||Enjoy a Delicious & Healthy Lunch
|1:15PM - 2:30PM||A Focus on Time in Range, Unmet Needs and Modern Management of Type 1 Diabetes
Jeremy H. Pettus, MD
|2:30PM - 3:30PM||Practical Application of Injectable Agents and Their Cardiovascular Effects: Individualized Treatment Strategies
Schafer Boeder, MD
|3:30PM - 4:30PM||Combined Patient-Provider Workshop: Doctors Are From Mars, Patients Are From Venus
William Polonsky, PhD, CDE, and Steven V. Edelman, MD
|4:30PM - 5:00PM||Closing Session
This session will discuss participant observations and insights gained regarding the important and difficult issues that people with diabetes face on an everyday basis.
Session held in tandem with the TCOYD Conference & Health Fair for people with diabetes.
Registration for this conference is now closed.
SPEAKERS & FACULTY
Additional speakers will be announced soon
*extra-relatable faculty (they’re living with type 1)
*Steven V. Edelman, MD
TCOYD Founder & Director
Dr. Edelman is the founder and director of Taking Control Of Your Diabetes (TCOYD), a professor of medicine in the Division of Endocrinology, Diabetes & Metabolism at the University of California, San Diego (UCSD) and the Veterans Affairs (VA) Healthcare System of San Diego. He is also the director of the Diabetes Care Clinic at the VA Medical Center. Dr. Edelman, who has type 1 diabetes himself, has written more than 200 articles, five books, and has won numerous awards for teaching and humanitarianism. He has been chosen by the medical students at UCSD as the ‘teacher of the year’ numerous times. Among his many honors, Dr. Edelman has received the ‘Diabetes Educator Of The Year’ award by the American Diabetes Association, the ‘Distinction in Endocrinology’ award by the American Association of Clinical Endocrinologists, and named ‘Top 1% of U.S. Endocrinologists’ by US News and World Report
William Polonsky, PhD, CDE
Clinical Psychologist; Founder & CEO, Behavioral Diabetes Institute
Dr. Polonsky is President and Founder of the Behavioral Diabetes Institute, the world's first organization totally dedicated to studying and addressing the unmet psychological needs of people with diabetes. He is also Associate Clinical Professor in Psychiatry at the University of California, San Diego. Dr. Polonsky received his PhD in clinical psychology from Yale University and has served as Senior Psychologist at the Joslin Diabetes Center in Boston, faculty member at Harvard Medical School and Chairman of the National Certification Board for Diabetes Educators. A licensed clinical psychologist and certified diabetes educator, he received the American Diabetes Association’s 2014 Richard R. Rubin Award for distinguished contributions to behavioral medicine and psychology. Dr. Polonsky’s most recent research projects have focused on quality of life in diabetes, diabetes-related distress and depression, hypoglycemic fear, and glucose monitoring behavior and attitudes in people living with diabetes.
*Jeremy Pettus, MD
Type 1 Track and Professional Education Director, Endocrinologist, Associate Professor of Medicine, UCSD School of Medicine
Dr. Jeremy Pettus was diagnosed with type 1 diabetes when he was 15 years old. Since that time he has dedicated his career to educating and treating others like himself. He is currently an Endocrinologist and Assistant Professor of Medicine at the University of California, San Diego. There, he focuses primarily on clinical trials to develop and test new and innovative therapies for people living with diabetes. These include studies ranging from medications to reverse or slow the disease once it occurs, to islet cell transplantation strategies, to device studies such as artificial pancreas technology. As somebody who has the disease himself, sees patients with type 1, and is actively working on curing/treating the disease, we are honored to have him as our Type 1 Track director. Dr. Pettus travels across the country and the world meeting other leading physicians and scientists and brings this information directly to TCOYD conference participants.
Schafer Boeder, MD
Type 2 Track Co-Director, Endocrinologist, Assistant Professor of Medicine, UCSD School of Medicine
Schafer Boeder, MD, is a board-certified endocrinologist who diagnoses and treats people with a variety of endocrine conditions, with a particular focus on diabetes. His research is focused on new medications, devices, and technologies to help patients with Type 1 and Type 2 diabetes. He is active in patient education through organizations such as Taking Control of Your Diabetes, where he speaks on topics such as current and future therapies for diabetes. Dr. Boeder was chief fellow during his endocrinology and metabolism fellowship at UC San Diego School of Medicine, where he also completed his residency in internal medicine. He earned his medical degree from Eastern Virginia Medical School in Norfolk, Va. He is board certified in internal medicine and endocrinology, diabetes and metabolism.
At course completion, participants should be able to:
|1. Identify the different pathophysiologic defects associated with type 2 diabetes and how all the pharmacologic agents (oral and injectable) address these specific abnormalities.||7. Design a treatment plan for multiple daily injection regimens and insulin pump therapy.|
|2. Develop individualized treatment strategies based on the living standards of care and patient characteristics.||8. Explain how to interpret continuous glucose monitoring (CGM) data.|
|3. Discuss the recently published cardiovascular-renal outcome trials on oral and injectable type 2 medications.||9. Demonstrate the ability to select effective therapeutic adjustments based on CGM trending or rate of change arrows, time in range, and standard deviation.|
|4. Summarize the most up-to-date clinical information on GLP-1 RA and SGLT-2 inhibitors.||10. Recognize the physical and emotional barriers that prevent patients with diabetes from being persistent and adherent to their therapeutic regimen(s).|
|5. Evaluate the use of SGLT-2 and GLP-1 RA in patients who have cardiovascular risks factors and are at risk or have a history of atherosclerotic cardiovascular disease (ASCVD).||11. Employ innovative and dynamic strategies for communication with patients to strengthen provider-patient relations and improve patient outcomes.|
|6. Discuss approaches to combination therapy with the currently available oral agents, as well as physician and patient-directed insulin titration strategies and the basal-bolus approach.|
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of California, San Diego School of Medicine and Taking Control of Your Diabetes. The University of California, San Diego School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
AMA: The University of California, San Diego School of Medicine designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses: For the purposes of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credits™ issued by organizations accredited by the ACCME. For the purpose of re-licensure, the California Board of Registered Nursing accepts AMA PRA Category 1 credits™ (report up to 6.0 hours of credit and list “CME Category 1” as the provider number).
Physician Assistants: The AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 6.0 hours of Category 1 credit for completing this program.
Certified Diabetes Educators: The University of California, San Diego is accredited by the ACCME, which is on the NCBDE list of approved providers.
Pharmacist Accreditation Statement
Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Global Education Group designates this continuing education activity for 6.0 contact hour(s) (0.6 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number – 0530-9999-20-092-L01-P)
This is a knowledge based activity.
Attention HCPs from outside of the US: To see if you are eligible to receive CME credits check here.
GET YOUR CME CREDITS HERE!
Attend the Conference. Get the Code. Get Your Credits!
After you have attended the Making the Connection conference click below to claim your CME credit. Be sure to reference your credit access code, found in the materials you will receive on the day of the conference.